转发：总结一下最近几个关于新冠药物和疫苗的正面新闻

[薄荷糖]

1，吉利德做了一个回顾研究，比较使用瑞德西韦的病人和症状类似但不使用瑞德西韦的病人，发现死亡率下降了62%。

Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patients

The findings show that 7.6% of patients treated with remdesivir died compared with 12.5% of patients in the analysis who did not receive remdesivir treatment.

www.cnbc.com

2，Regeneron新冠单抗前几天已经开始三期临床，夏天结束前会看到结果。川普新冠单抗可以用来治疗也可以预防，在疫苗出来之前可以用来保护高危人群。

Regeneron signs a $450 million contract with the U.S. government for its coronavirus therapy

Regeneron Pharmaceuticals said on Tuesday the U.S. government has granted the drugmaker a $450 million contract to make and supply its double antibody cocktail that is being tested against Covid-19.

www.cnbc.com

3，在得到CEPI的4亿投资之后，Novavax又得到川普政府的16亿投资。Operation warp speed的拨款数量基本上可以理解为Fauci本人对这个疫苗看好的程度，目前的分配是牛津疫苗12亿，Moderna和强生都是4亿多。

Novavax receives highest funding to develop COVID-19 vaccine

Vaccine developer Novavax was awarded over $1.6 billion by Operation Warp Speed to produce a vaccine against COVID-19.

abcnews.go.com

4, 辉瑞疫苗的抗体数据非常好（都是RNA疫苗，辉瑞疫苗10毫克产生的中和抗体数量好于Moderna疫苗100毫克连打两针的数量），CEO希望10月份疫苗能够被批准。

Pfizer CEO says it's 'feasible' FDA could approve COVID-19 vaccine candidate by October

The latest Speed Read,/speed-reads,,speed-reads, breaking news, comment, reviews and features from the experts at The Week

theweek.com

5，吉利德已经启动inhale版本瑞德西韦的临床实验，如果成功的话可以用于非住院病人，早发现早治疗。

Gilead begins testing of inhaled version of remdesivir for Covid-19

Gilead Sciences has launched a Phase Ia clinical trial of inhaled version of remdesivir to treat Covid-19 patients in the outpatient setting.

www.clinicaltrialsarena.com

 

[ccc]

疫苗，至少1年以后。

 

[贵圈]

有毒就有解药。但是何时才有。真的很难说。

 

[Ottawa005]

真的都是很不錯的正面新聞。

 

[superlover]

不看好疫苗